Our Posts

Varubi, an injectable drug used to manage chemotherapy-induced nausea and vomiting, has been linked to severe allergic reactions, including anaphylaxis and anaphylactic shock. These reactions can occur immediately after administration and may be life-threatening. Parker Waichman LLP is investigating cases involving Varubi and offers legal assistance to affected patients. The firm emphasizes the importance of hiring a product liability lawyer to pursue compensation for medical costs and other damages. Tesaro Inc., the manufacturer, has warned healthcare providers about these risks and advised caution in patients with known allergies.

Parker Waichman LLP specializes in personal injury cases, including those involving non-FDA-approved stem cell eye treatments that have caused severe vision loss or blindness. The firm offers free consultations and operates on a contingency fee basis, meaning clients pay no fees unless they win. The FDA has taken legal action against a South Florida clinic for using misbranded drugs in these treatments. Victims are encouraged to seek legal advice promptly to maximize their chances of compensation. Parker Waichman LLP has a strong track record in securing settlements and verdicts.

Taxotere, a chemotherapy drug used for breast cancer, has been linked to permanent hair loss, unlike other similar treatments. Approved by the FDA in 1996, its label was updated in 2015 to warn of this risk. Many patients were unaware of the potential for permanent alopecia, leading to numerous lawsuits. Research indicates that 10-15% of breast cancer survivors treated with Taxotere may experience this side effect. Legal actions claim Sanofi-Aventis, the manufacturer, failed to adequately warn U.S. patients, despite earlier warnings in Europe and Canada.

Complaints to the FDA about DePuy Pinnacle Hip Implants with metal liners have surged recently. From July to September, 709 adverse event reports (AERs) were submitted, with 201 involving metal liners. In 2011, the FDA received 1,266 AERs related to these implants, 450 of which involved metal liners. If the trend continues, the FDA could receive 1,700 AERs by year-end, with over 600 involving metal liners. Complaints about ceramic and polyethylene liners are significantly lower.

A plaintiff in a talcum powder lawsuit has requested the U.S. Judicial Panel on Multidistrict Litigation to centralize ovarian cancer lawsuits into a multidistrict litigation (MDL) in the Southern District of Illinois. These lawsuits claim that using talcum powder, such as Johnson & Johnson's products, as a feminine hygiene product may increase ovarian cancer risk. Coordinating pretrial proceedings could prevent duplicate discovery and inconsistent rulings. Despite studies suggesting a link since the 1970s, plaintiffs argue Johnson & Johnson failed to warn about the risks. Recent trials have resulted in significant damage awards.

The NeuroBlate System, a laser-based surgical probe by Monteris Medical, is used for minimally invasive brain tumor removal. Despite its innovative design, the device has been linked to serious side effects due to defects, including overheating and inaccurate temperature readings, leading to brain tissue damage. The FDA issued a Class I recall and warned of potential risks. Legal investigations are underway, and affected patients may seek compensation. Parker Waichman LLP offers free consultations for those impacted by NeuroBlate-related complications.

Parker Waichman LLP, a national plaintiffs' law firm, is accepting new clients who have been injured by defective hernia mesh manufactured by C.R. Bard and Davol. The firm is investigating claims of severe injuries caused by these products and aims to secure substantial financial compensation for affected individuals. Parker Waichman LLP is involved in significant litigation against Bard, including a major lawsuit in Rhode Island. The firm offers free case evaluations and emphasizes the importance of timely filing claims to avoid forfeiting rights.

Hernia mesh repair is a common surgical procedure to prevent hernia recurrence, but it carries risks of complications such as bleeding, abscesses, and bowel issues. A study published in 2016 in JAMA found that while mesh reduces hernia recurrence, it also increases complication rates compared to non-mesh repairs. The FDA notes that many mesh devices are approved through the 510(k) process, which lacks rigorous clinical testing. Legal assistance is available for those affected by hernia mesh complications.

In January 2017, researchers identified a link between talcum powder use for feminine hygiene and an increased risk of ovarian cancer. The study, published in the European Journal of Cancer Prevention, involved a meta-analysis of 24 studies with 302,000 patients. Findings showed a 20% higher risk for women using talc. Lawsuits against Johnson & Johnson allege the company concealed these risks, leading to significant jury verdicts. Talc, often containing asbestos, has been linked to cancer, prompting legal actions and substantial financial penalties for J&J.

A St. Louis jury awarded $110 million to a Virginia woman who claimed Johnson & Johnson's talcum powder products caused her ovarian cancer. The plaintiff, who used the products for over 40 years, was diagnosed in 2012. This verdict is the fourth large one against J&J since 2016, with previous awards of $55 million, $70 million, and $72 million. The jury found J&J mostly at fault, citing their failure to warn consumers about cancer risks. Over a thousand similar lawsuits are pending, with more trials scheduled. Research has linked talc use to increased ovarian cancer risk.

Stryker's 2014 settlement for Rejuvenate and ABG II metal-on-metal hip implants, initially covering patients with revision surgery before November 3, 2014, may now include those implanted until December 19, 2016. The implants were recalled due to fretting and corrosion risks, potentially causing adverse tissue reactions. Stryker faces additional lawsuits for other hip implants like the Accolade and LFIT V40 femoral heads, which were also recalled for similar issues. Metal-on-metal hip implants have been criticized for releasing metal ions, leading to complications and early revision surgeries.

Nationwide lawsuits are being filed against Endologix, Inc. due to injuries from their AFX endovascular AAA systems, which were recalled by the FDA for significant risks. These devices, intended to treat abdominal aortic aneurysms, may cause severe complications, leading to high medical costs and lost income. Parker Waichman LLP is evaluating claims and offers free consultations, working on a contingency-fee basis to help victims secure compensation. It's crucial to act quickly due to limited timeframes for filing lawsuits.

The FDA is set to announce its decision on Bayer's permanent birth control device, Essure, in February 2016. This follows a review of data from an Obstetrics and Gynecology Devices panel meeting, prompted by over 5,000 reports of adverse events, including organ perforation and allergic reactions. The device, which involves metal coils inserted into fallopian tubes, has been classified as a high priority issue. Allegations of falsified clinical data and conflicts of interest have been raised, with calls for the revocation of its premarket approval.

The FDA has mandated that companies producing benzocaine-based over-the-counter medications revise their marketing strategies, particularly for products aimed at children under two years old, due to the risk of methemoglobinemia. This condition reduces oxygen levels in the blood and poses significant health risks. The FDA requires new warning labels on these products and has threatened regulatory action against non-compliant companies. Despite previous warnings, benzocaine products were still marketed for teething pain relief in young children until 2018. The FDA's measures aim to prevent further cases and ensure consumer safety.

The FDA is intensifying scrutiny of metal-on-metal hip implants due to concerns about chromium and cobalt release into patients' bloodstreams, which could cause adverse effects like metallosis and cobalt poisoning. Following the recall of DePuy's ASR hip implant, the FDA has mandated DePuy and other manufacturers to assess implant safety and failure rates. This marks a significant use of the FDA's authority to study devices post-approval. Manufacturers have 30 days to submit their plans to the FDA. Legal assistance is available for affected individuals.

Xeljanz, a drug for psoriatic and rheumatoid arthritis and ulcerative colitis, has been linked to increased risks of blood clots, prompting an FDA warning. Parker Waichman LLP is investigating lawsuits against Pfizer, the manufacturer, due to rising reports of complications. The FDA's black-box warning highlights the dangers, especially for rheumatoid arthritis patients on higher doses. If affected, individuals may seek compensation through legal action. The firm offers free consultations to discuss potential claims for injuries or wrongful deaths related to Xeljanz.

The American Academy of Pediatrics has issued a report warning against the use of codeine in children due to the risk of potentially deadly reactions. Codeine, an opioid used for pain relief and cough suppression, can be metabolized into morphine at varying rates in children, sometimes leading to dangerous levels. Despite its common prescription, especially post-surgery, the risks are deemed to outweigh the benefits. Regulatory bodies like the FDA and WHO have also issued warnings. The report highlights the need for safer alternatives and further research into pain management for children.

The FDA and Davol, Inc. have expanded a Class 1 recall of Bard Composix Kugel Mesh Patches, used for ventral hernia repair, due to the risk of the "memory recoil ring" breaking under stress. This can cause bowel perforation or chronic enteric fistulae. The recall now includes all lots of the oval "midline" size and certain lots of large oval and circle products manufactured before 2004. Healthcare professionals should stop using and return affected products. Patients with these devices should seek medical attention if they experience symptoms like abdominal pain or fever.

Bair Hugger warming devices, used in surgeries, have been linked to serious infections, prompting lawsuits. Parker Waichman LLP is handling these cases, aiming to secure full compensation for affected patients. The device, manufactured by 3M and Arizant Healthcare, allegedly allows bacteria to contaminate surgical sites, leading to severe infections. The firm has a strong track record in personal injury and product liability cases, having recovered over $2 billion for clients. They offer free consultations to evaluate potential claims and ensure timely filing within the statute of limitations.

The FDA has issued a Class I recall, the most severe type, for Vyaire Medical's Resuscitation Device & Broselow Convenience Kit due to a design flaw. This defect can cause the device to stick to the operator's elbow, potentially delaying oxygen delivery to patients who cannot breathe independently, leading to serious injury or death. Class I recalls are reserved for products that pose a significant risk to health. Vyaire has previously recalled other devices for similar safety concerns.

Parker Waichman LLP is investigating a potential link between the Mirena® IUD and Rheumatoid Arthritis (RA). The Mirena® IUD is a hormonal device used for birth control. Women who suspect they developed RA due to Mirena® are encouraged to seek medical advice and may be eligible for legal assistance. Parker Waichman offers free consultations to evaluate potential cases. RA is an autoimmune disease causing joint inflammation, with symptoms like joint pain and stiffness. Legal support is available for affected individuals.

Parker Waichman LLP specializes in complex legal cases, focusing on protecting victims' rights and achieving results. They offer free consultations for individuals who took Invokana for type 2 diabetes and suffered kidney injuries, ketoacidosis, or amputations. Time is critical, and delaying contact may risk losing rights. Reach out to Parker Waichman LLP at 1-800-YOURLAWYER (1-800-968-7529) or fill out their consultation form to discuss your rights and claim options with an experienced Invokana lawyer.

King Bio recalled three products due to microbial contamination, posing serious health risks. Affected consumers may have claims for damages. Parker Waichman LLP advocates for clients, emphasizing the responsibility of manufacturers to ensure safety. To qualify for a lawsuit, proof of liability is required, such as manufacturing defects or failure to warn. Compensation depends on medical costs, lost wages, and emotional suffering. Parker Waichman LLP offers contingency-based representation, meaning no fees unless compensation is recovered. Prompt action is crucial due to statutes of limitations. Contact them for legal assistance.

Xarelto is an anticoagulant medication used to prevent blood clots, reducing the risk of heart attacks and strokes. Developed by Johnson & Johnson and Bayer, it has been linked to severe internal bleeding, leading to over 18,000 adverse effect reports and 370 fatalities. The FDA has issued a "Black Box Warning" due to these risks. Lawsuits claim the manufacturers misrepresented the drug's dangers. Parker Waichman LLP offers legal support for those affected, seeking compensation for injuries or fatalities related to Xarelto use.